244 related articles for article (PubMed ID: 12813983)
21. [Angiotensin 1-antagonists: primary therapeutic option in arterial hypertension, too].
Traut
Dtsch Med Wochenschr; 2003 Jan; 128(4):161; discussion 161-2. PubMed ID: 12589590
[No Abstract] [Full Text] [Related]
22. Prevention of cardiovascular morbidity with angiotension receptor blockade: life after LIFE.
Diabet Med; 2002 Sep; 19 Suppl 5():6. PubMed ID: 12207800
[No Abstract] [Full Text] [Related]
23. The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.
Fossum E; Moan A; Kjeldsen SE; Devereux RB; Julius S; Snapinn SM; Edelman JM; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Dahlöf B;
J Am Coll Cardiol; 2005 Sep; 46(5):770-5. PubMed ID: 16139123
[TBL] [Abstract][Full Text] [Related]
24. Reduction of resistance artery stiffness by treatment with the AT(1)-receptor antagonist losartan in essential hypertension.
Park JB; Intengan HD; Schiffrin EL
J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):40-5. PubMed ID: 11967798
[TBL] [Abstract][Full Text] [Related]
25. [When compliance doesn't work out. Calculate the risk of stroke for hypertensive patients!].
MMW Fortschr Med; 2004 Feb; 146(7):61. PubMed ID: 15347060
[No Abstract] [Full Text] [Related]
26. Diuretics in the LIFE study.
Kato J; Eto T
Lancet; 2004 Jul 31-Aug 6; 364(9432):413; author reply 413-4. PubMed ID: 15288732
[No Abstract] [Full Text] [Related]
27. Angiotensin II receptor antagonists: enlarging therapeutic possibilities in arterial hypertension.
Plante GE
Can J Cardiol; 1999 Nov; 15 Suppl F():4F-6F. PubMed ID: 10579746
[No Abstract] [Full Text] [Related]
28. [To protect the hypertensive patient from complications. Blood pressure lowering is not equal to blood pressure lowering].
MMW Fortschr Med; 2003 Nov; 145(45):51. PubMed ID: 14712789
[No Abstract] [Full Text] [Related]
29. Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: the Losartan Intervention For End point reduction in hypertension (LIFE) study.
Olsen MH; Wachtell K; Beevers G; Dahlöf B; Devereux RB; de Faire U; Fyhrquist F; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Narayan P; Nieminen MS; Omvik P; Oparil S; Wedel H
Am Heart J; 2009 Jan; 157(1):177-84. PubMed ID: 19081416
[TBL] [Abstract][Full Text] [Related]
30. ARB superior to beta blocker in preventing adverse outcomes in older, high-risk hypertensive patients.
Geriatrics; 2002 May; 57(5):63-4. PubMed ID: 12040595
[No Abstract] [Full Text] [Related]
31. [A suitable antihypertensive drug of significance. Protection of heart, brain and kidney is decisive].
MMW Fortschr Med; 2005 May; 147(19):49. PubMed ID: 15940939
[No Abstract] [Full Text] [Related]
32. [Kidney protection leads to heart protection, too].
MMW Fortschr Med; 2006 Aug; 148(33-34):57. PubMed ID: 16981393
[No Abstract] [Full Text] [Related]
33. [Optimizing antihypertensive therapy. In 5 years 35,000 strokes are preventable].
MMW Fortschr Med; 2004 Jul; 146(27-28):52. PubMed ID: 15526671
[No Abstract] [Full Text] [Related]
34. Can losartan prevent new-onset atrial fibrillation in hypertensive patients more effectively than atenolol?
Nattel S
Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):332-3. PubMed ID: 16265553
[No Abstract] [Full Text] [Related]
35. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
[TBL] [Abstract][Full Text] [Related]
36. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
[TBL] [Abstract][Full Text] [Related]
37. Influence of losartan and atenolol on memory function in very elderly hypertensive patients.
Fogari R; Mugellini A; Zoppi A; Derosa G; Pasotti C; Fogari E; Preti P
J Hum Hypertens; 2003 Nov; 17(11):781-5. PubMed ID: 14578918
[TBL] [Abstract][Full Text] [Related]
38. [Primary prevention of stroke. What helps--what does not help? The guidelines of the German Society of Neurology briefly summarized].
Diener HC
MMW Fortschr Med; 2003; 145 Suppl 1():9-10. PubMed ID: 12958797
[No Abstract] [Full Text] [Related]
39. [LIFE study proves preventive action. With losartan to do even more against stroke].
Baumgart P
MMW Fortschr Med; 2003; 145 Suppl 1():7-8. PubMed ID: 12958796
[No Abstract] [Full Text] [Related]
40. Long-term plasma catecholamines in patients with hypertension and left ventricular hypertrophy treated with losartan or atenolol: ICARUS, a LIFE substudy.
Fossum E; Olsen MH; Høieggen A; Wachtell K; Reims HM; Ibsen H; Julius S; Kjeldsen SE
J Hum Hypertens; 2004 Jun; 18(6):375-80. PubMed ID: 15057253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
